Li Z, Wang X, Zhang W, Yang W, Xu B, Hu W
Insulin as a catalyst to recombinant DNA technology
If youre deficient in B12, these shots can be a powerful tool, boosting energy, supporting metabolism, and helping you stay active and motivated
Primary candidates for GLP-1 therapy include: Patients with type 2 diabetes and inadequate glycemic control despite metformin therapy Individuals with type 2 diabetes and established atherosclerotic cardiovascular disease Patients with type 2 diabetes and multiple cardiovascular risk factors (hypertension, dyslipidemia, obesity) Adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with weight-related comorbidities Patients with metabolic syndrome who have not achieved adequate risk factor control with lifestyle modification For patients with dyslipidemia, GLP-1 agents may be particularly valuable when combined with statin therapy in those who have not reached LDL-C goals or who have persistent hypertriglyceridemia despite statin treatment
As a result, specialty medications (including GLP-1s) may be designated as either medical benefit drugs or pharmacy benefit drugs based on their mode of delivery and approved uses ( [10] )
